Artelo Biosciences, Inc. announced that it will receive $20,096,972 in funding on May 13, 2022. The company will issue common shares in the transaction. The company will issue securities pursuant to exemption provided under Regulation D.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.39 USD | +2.21% | +3.74% | -0.71% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-0.71% | 4.39M | |
+9.39% | 114B | |
+11.50% | 104B | |
-13.97% | 22.41B | |
-1.05% | 22.28B | |
-5.29% | 19.07B | |
-38.29% | 18B | |
-4.44% | 17.89B | |
+6.79% | 14.28B | |
+35.29% | 12.55B |
- Stock Market
- Equities
- ARTL Stock
- News Artelo Biosciences, Inc.
- Artelo Biosciences, Inc. announced a financing transaction